Through comprehensive investigations in MYC-driven colorectal cancer and Burkitt Lymphoma cells, scientists demonstrated that MYC upstream region did not facilitate cap-independent translation, but instead orchestrated resistance to PI3K inhibitors.
[Oncogene]